ALK-ABELLÓ A/S: Financial statements 2018
CVR: 63717916
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
ALK-ABELLÓ A/S (CVR 63717916) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 2,915,000,000 and a net result of DKK -170,000,000 compared with DKK -158,000,000 the year before. That is an increase of 0.2% compared with the year before. The profit margin was -5.8%. Equity in the 2018 report amounted to DKK 3,179,000,000. The solvency ratio was 65.3%.
- Revenue
- DKK 2,915,000,000
- Gross Profit
- DKK 1,633,000,000
- Profit/Loss
- DKK -170,000,000
- Equity
- DKK 3,179,000,000
- Total Assets
- DKK 4,865,000,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 2.9B | 1.6B | -170M | 3.2B | - |
| 2017 | 2.9B | 1.6B | -158M | 3.3B | - |
| 2016 | 3B | 2B | 270M | 2.9B | - |
| 2015 | 2.6B | 1.7B | 344M | 2.7B | - |
| 2014 | 2.4B | 1.7B | 181M | 2.4B | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
ALK-ABELLÓ A/S has published its interim report for the period January 1, 2018 to September 30, 2018.
ALK-ABELLÓ A/S has published its interim report for the period January 1, 2018 to June 30, 2018.
ALK-ABELLÓ A/S has published its interim report for the period January 1, 2018 to March 31, 2018.
ALK-ABELLÓ A/S has published its annual report for 2017. Revenue came to DKK 2,910,000,000, and the net result was DKK -158,000,000.
As of March 12, 2018, Gonzalo de Miquel Serra has joined the board of directors of ALK-ABELLÓ A/S.
As of March 12, 2018, Per Toft Valstorp has left the board of directors of ALK-ABELLÓ A/S.
As of March 12, 2018, Anders Gersel Pedersen has left the board of directors of ALK-ABELLÓ A/S.
As of January 1, 2018, Søren Jelert is registered as director of ALK-ABELLÓ A/S.
About ALK-ABELLÓ A/S
ALK-ABELLÓ A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 1961. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ALK A/S and ALLERGOLOGISK LABORATORIUM A/S. The management consists of Peter Halling and Claus Steensen Sølje. The board consists of Anders Hedegaard (chair), Lene Skole-Sørensen, Alan Main and Bertil Erik Lindmark. The company is owned by LUNDBECKFOND INVEST A/S. The company has 1,017 employees (2026). In 2025, the company reported revenue of DKK 6,312,000,000 and a net result of DKK 1,197,000,000 compared with DKK 815,000,000 the year before. Equity in the 2025 report amounted to DKK 6,445,000,000.